The Effect of Trace Amounts of Tissue Factor on Thrombin Generation in Platelet Rich Plasma, its Inhibition by Heparin

Summary

Amounts of human brain thromboplastin that do not stimulate thrombin generation in platelet poor plasma, were shown to advance by about 4 min an explosive formation of thrombin that occurs after recalcification in the presence of blood platelets. This synergistic effect is inhibited by the specific thrombin inhibitor hirudin and mimicked by adding low concentrations (< 5 nM) of thrombin to platelet rich plasma. It is our conclusion that, small amounts of thrombin, generated under the influence of thromboplastin induced procoagulant activity in the blood platelets. This activity is most likely mainly due to procoagulant phospholipids. Heparin inhibits this effect and retards the explosive thrombin formation. It does not, however, diminish the peak amount of thrombin eventually formed, because heparin neutralizing material released from the activated platelets quenches the heparin effect.

Key words

Platelets - Tissue factor - Thrombin - Heparin

• References

• 1 Kloprogge E, Haas GM de, Gorter G, Akkerman JW N. dProperties of PAF-acether-induced platelet aggregation and secretion. Studies in gel-filtered platelets Thromb Res 1983; 29: 595-609
• 2 Bevers EM, Comfurius P, van Rijn JL M L, Hemker HC, Zwaal RF. Generation of prothrombin converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 1982; 122: 429-436
• 3 Rosing J, van Rijn JL M L, Bevers EM, van Dieijen G, Comfurius P, Zwaal RF. The role of activated human platelets in prothrombin and factor X activation. Blood 1985; 65: 319-332
• 4 Breederveld K, Giddings JC, ten Cate JW, Bloom AL. The localization of factor V within normal human platelets and the demonstration of a platelet-factor V antigen in congenital factor V deficiency. Br J Haematol 1975; 29: 405-412
• 5 Chesney CM, Pifer DD, Colman RW. The role of platelet factor V in prothrombin conversion. Thromb Res 1983; 29: 75-84
• 6 Conley LC, Hartman RC, Lalley JS. The relationship of heparin activity to platelet concentration. Proc Soc Exp Biol Med 1948; 69: 284-287
• 7 Poplawski A, Niewarowski S. Method for determining antiheparin activity of platelets and erythrocytes. Thromb Diafh Haemorrh 1965; 13: 149-154
• 8 Moor S, Pepper DS, Cash JD. The isolation and characterization of platelet factor 4 released from thrombin aggregated washed human platelets and its dissociation into subunits and the isolation of membrane-bound antiheparin activity. Biochim Biophys Acta 1975; 378: 370-384
• 9 Walsh PN. Platelet mediated trigger mechanisms in the contact phase of blood coagulation. Sem Thromb Hemostas 1987; 13: 86-94
• 10 Walsh PN, Griffin JH. Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI. Blood 1981; 57: 106-118
• 11 Jesty J, Nemerson Y. Purification of factor VII from bovine plasmaReaction with tissue factor and activation of factor X. J Biol Chem 1974; 249: 509-515
• 12 Owren PA, Aas K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Inv 1951; 3: 201-218
• 13 Hemker HC, Willems G, Béguin S. A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemostas 1986; 56: 9-17
• 14 Tracy PB, Eide LL, Bowie EJ W, Mann KG. Radioimmunoassay of factor V in human plasma and platelets. Blood 1982; 60: 59-63
• 15 Hemker HC. The mode of action of heparin in plasma. In: Thrombosis and Haemostasis. Verstraete M, Vermylen J, Lijnen R, Arnout J. (eds) Leuven University Press; Leuven: 1987. pp 17-36
• 16 Bizzozero G. Sur un nouvel élément morphologique du sang chez les mammifères et son importance dans la thrombose et dans la coagulation. Archiv Ital Biol 1882; 345-362
• 17 Biggs R, Macfarlane RG. Human Blood Coagulation. Blackwell Scientific Publications, Oxford; 1953
• 18 Shuman MA, Majerus PW. The measurement of thrombin in clotting blood by radioimmunoassay. J Clin Invest 1976; 58: 1249-1258
• 19 Biggs R, Nossel HL. Tissue extract and the contact reaction in blood coagulation. Thromb Diath Haemorrh 1961; 6: 1-14
• 20 Josso F, Prou-Wartelle O. 4. Interaction of tissue factor and factor VII at the earliest phase of coagulation. Thromb Diath Haemorrh 1965; Suppl 17: 35-44
• 21 Østerud B, Rappaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74: 5260-5264
• 22 van Putten J, Ruit M, van de Beunis M, Hemker HC. Heparin neutralization during collection and processing of blood inhibited by pyridoxal 5’-phosphate. Haemostasis 1984; 253-261